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Abstract
Synthetic oligodeoxynucleotides containing unmethylated CpG motifs (CpG) stimulate innate immune responses.
Phosphoinositide 3-kinase (PI3K) has been implicated in CpG-induced immune activation; however, its precise role has
not yet been clarified. CpG-induced production of IL-10 was dramatically increased in macrophages deficient in PI3Kc
(p110c
2/2). By contrast, LPS-induced production of IL-10 was unchanged in the cells. CpG-induced, but not LPS-induced, IL-
10 production was almost completely abolished in SCID mice having mutations in DNA-dependent protein kinase catalytic
subunit (DNA-PKcs). Furthermore, wortmannin, an inhibitor of DNA-PKcs, completely inhibited CpG-induced IL-10
production, both in wild type and p110c
2/2 cells. Microscopic analyses revealed that CpG preferentially localized with DNA-
PKcs in p110c
2/2 cells than in wild type cells. In addition, CpG was preferentially co-localized with the acidic lysosomal
marker, LysoTracker, in p110c
2/2 cells, and with an early endosome marker, EEA1, in wild type cells. Over-expression of
p110c in Cos7 cells resulted in decreased acidification of CpG containing endosome. A similar effect was reproduced using
kinase-dead mutants, but not with a ras-binding site mutant, of p110c. Thus, it is likely that p110c, in a manner independent
of its kinase activity, inhibits the acidification of CpG-containing endosomes. It is considered that increased acidification of
CpG-containing endosomes in p110c
2/2 cells enforces endosomal escape of CpG, which results in increased association of
CpG with DNA-PKcs to up-regulate IL-10 production in macrophages.
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Introduction
Oligodeoxynucleotides containing unmethylated CpG motifs
(CpG) are powerful immune adjuvants that induce the produc-
tion of cytokines, including IL-6, IL-10, IL-12, IFN-a/b, and
TNF-a [1,2]. Although previous studies have established that
CpG-induced immune responses are mediated by endosomal
TLR9 [3–5], cytoplasmic DNA-PKcs are also involved in CpG-
signaling independent of TLR9 [6,7]. Thus, intracellular
trafficking of CpG is critical to select downstream signaling
molecules, which determine the cytokine species produced by
macrophages [7,8].
Phosphoinositide 3-kinase (PI3K) has been reported to be both
a positive and negative regulator of CpG-mediated cytokine
production. CpG-induced IL-12 production is increased in
plasmacytoid dendritic cells (pDC) from p85a
2/2 mice, and by
treatment of wild-type pDC with wortmannin [9]. Likewise, CpG-
induced iNOS expression is increased by treating RAW264.7 cells
with wortmannin [10]. By contrast, another group has reported
that wortmannin inhibits CpG-induced production of IL-12, IL-6,
TNF-a, and NO from RAW264.7 cells [11]. This inhibition has
been considered to be the result of wortmannin-mediated
disruption of class III PI3K signaling, which is responsible for
CpG uptake [11]. Similarly, wortmannin inhibits CpG-induced
IL-12 production by inhibiting CpG internalization in mouse-
derived bone marrow cells [12]. In human pDC, another PI3K
inhibitor, LY294002, also inhibits CpG-induced type I IFN
production [13]. In this case, the uptake and endosomal trafficking
of CpG are not affected, but nuclear translocation of IRF-7 was
inhibited by LY294002, and also, by a specific inhibitor of PI3Kd,
IC87114 [13]. In addition, the PI3K/mTOR/p70S6K pathway
plays a substantial role in the spatial interaction of TLR9/
MyD88/IRF7, which is indispensable for the induction of type I
IFN production by pDC [14]. These reports have indicated that
PI3Ks play some roles in trafficking of CpG itself or its
downstream molecules.
Pan- and/or some other specific PI3K inhibitors were used in
all of the previous studies described above. All of these inhibitors
bind competitively to the ATP binding pocket of PI3Ks and block
kinase activity. Since DNA-dependent protein kinase catalytic
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member of the PI3K-like kinase family, these inhibitors, even
isoform-specific inhibitors, more or less inhibit DNA-PKcs [15].
This makes it difficult to elucidate the precise role of DNA-PKcs
and PI3Ks in CpG-mediated cytokine production. In this paper,
we used class IB PI3K (p110c) knockout mice and SCID mice
having mutations in DNA-PKcs to estimate their roles in CpG-
mediated cytokine production. In agreement with a current
report, DNA-PKcs play a substantial role in CpG-mediated IL-
10 production in macrophages [7]. By contrast, p110c specifi-
cally down-regulates IL-10 production following CpG-stimula-
tion. Quantitative analysis of microscopic images showed that
CpG localized preferentially with DNA-PKcs in the cytosol in
p110c
2/2 cells to a greater extent than in wild-type cells. We
propose a novel regulatory role of p110c in CpG-induced
production of IL-10 through modulation of the intracellular
trafficking of CpG.
Results
p110c deficiency specifically increased IL-10 production
upon CpG stimulation in macrophages
Mouse macrophages generated IL-10 in response to CpG
(Fig. 1). Since PI3K has been implicated in the regulation of
TLR-induced IL-10 production [16], we tested the effect of
p110c depletion on IL-10 production. CpG-induced IL-10
production was dramatically increased in macrophages from
p110c
2/2 mouse (Fig. 1). Although IL-10 production sometimes
varied extremely between experiments, IL-10 production in wild
type mice was always approximately half of that in p110c
2/2
mice in each paired experiment. We also tested the cytokine
production using macrophages from p85a
2/2 mice, and from
p110d
KD/KD mice; neither displayed CpG-specific changes in IL-
10 production similar to what was seen with p110c
2/2 cells (data
not shown).
Figure 1. Increased IL-10 production following CpG stimulation
of p110c
2/2 cells. Macrophages from wild type (open bar) or p110c
/2
mice (solid bar) were incubated in 24-well plates with 10 ng/mL LPS,
200 ng/mL CpG, 50 mg/mL polyI:C or 200 nM Malp2 for 18 h. The
amount of IL-10 in the medium was determined by ELISA. The values
are the means 6 SD of duplicate cultures from three independent
experiments.
doi:10.1371/journal.pone.0026836.g001
Figure 2. Inhibition of CpG-induced IL-10 production by wortmannin. Macrophages from wild type (A, C) or p110c
2/2 mice (B, D) were pre-
incubated with 0.1 mM( + in A, B), or increasing concentration of wortmannin (C, D) for 15 min, followed by the addition of 10 ng/mL LPS (A, B) or
200 ng/mL CpG (A–D), for 18 h. The amount of IL-10 in the medium was determined by ELISA. The values are the means 6 SD of duplicate cultures
from three independent experiments.
doi:10.1371/journal.pone.0026836.g002
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but increased that induced by LPS
Macrophages were treated with a pan-PI3K inhibitor, wort-
mannin. CpG-induced IL-10 production was almost completely
inhibited by wortmannin while LPS-induced IL-10 production
was rather increased in wild type cells (Fig. 2A). The effect of
wortmannin on LPS-induced IL-10 production may be the result
of the inhibition of p110c, because the augmentation was not
observed in p110c
2/2 cells (Fig. 2B). However, wortmannin
inhibited severely CpG-induced IL-10 production in p110c
2/2
cells, as well as in wild type cells (Fig. 2C. D). The inhibition by
wortmannin was specific to IL-10 production, because IL-12
production was unchanged by the treatment (data not shown).
These data indicate that the target molecule of wortmannin
responsible for the suppression of CpG-induced IL-10 was not
p110c.
p110c-mediated negative regulation of IL-10 production
was independent of kinase activity
Since a pan-PI3K inhibitor, wortmannin, did not mimic the
effect of p110c deficiency on CpG-induced IL-10 production, we
next tested the effect of the p110c-specific inhibitor, AS252424, on
CpG-induced IL-10 production. C5a-induced Akt phosphoryla-
tion was completely abolished in p110c
2/2 cells (Fig. 3A) [17].
The result confirmed that the C5a action is dependent on p110c.
AS252424 inhibited the C5a-induced Akt phosphorylation
(Fig. 3A), indicating that the compound is a powerful tool for
investigating the role of p110c. Surprisingly, AS252424 did not
cause an increase in CpG-induced IL-10 production in the wild
type cells nor in p110c
2/2 cells (Fig. 2B, C). These data suggest
that the negative regulation of CpG-induced IL-10 production by
p110c was not dependent on its kinase activity.
CpG-induced IL-10 production was abolished in SCID
mice
Recently, an indispensable role of DNA-PKcs in CpG-induced
IL-10 production has been reported [7]. Since DNA-PKcs has a
PI3K-like catalytic domain, the kinase activity is susceptible to
wortmannin. As reported earlier [7], CpG-induced IL-10
production was defective in SCID mice (Fig. 4). Additionally,
wortmannin inhibited significantly CpG-induced IL-10 produc-
tion in wild type, whereas it did not affect this process in SCID
mice (Fig. 4). This result suggests that wortmannin suppressed
CpG-induced IL-10 production through inhibition of DNA-PKcs.
By contrast, LPS-induced IL-10 production in SCID was identical
to wild type with the same background mice (Fig. 4).
Co-localization of DNA-PKcs and CpG was increased in
p110c
2/2 cells
CpG is internalized via endocytosis and immediately moves into
the lysosomal compartment [5,18,19]. A recent study reported
that endosomal CpG preferentially induces IL-12 production, but,
Figure 3. Irrelevance of the kinase activity of p110c in the
regulation of IL-10 production. (A) Macrophages from wild type or
p110c
2/2 mice were pre-incubated with 10 mM AS252424 for 15 min,
followed by the addition of 100 ng/mL C5a for 5 min. Total cell lysates
from the treated cells were analyzed by Western blot. (B and C)
Macrophages from wild type (B) or p110c
2/2 mice (C) were pre-
incubated with increasing concentrations of AS252424 for 15 min,
followed by the addition of 200 ng/mL CpG for 18 h. The amount of IL-
10 in the medium was determined by ELISA. The values are the means
6 SD of duplicate cultures from three independent experiments.
doi:10.1371/journal.pone.0026836.g003
Figure 4. Failure of CpG to stimulate IL-10 production in SCID
mice. Macrophages from wild type (open bar) or SCID (solid bar) mice
were preincubated with 0.1 mM wortmannin (+) or vehicle (2) for
15 min, followed by the addition of 10 ng/mL LPS or 200 ng/mL CpG,
for 18 h. The amount of IL-10 in the medium was determined by ELISA.
The values are the means 6 SD of duplicate cultures from three
independent experiments.
doi:10.1371/journal.pone.0026836.g004
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cytoplasm and induces a greater amount of IL-10 [7]. Therefore,
we hypothesized that CpG localized to the endosomal compart-
ment in the wild type cells, and was more efficiently released into
the cytosol in p110c
2/2 cells. To quantify the co-localization of
CpG and DNA-PKcs, macrophages were incubated with
rhodamine-labeled CpG, fixed with formaldehyde, permeabilized,
and incubated with anti-DNA-PKcs antibody. The merged area
was calculated from the imaging data as described under materials
and methods. The Co-localization area of CpG and DNA-PKcs
was significantly increased in 110c
2/2 cells (Fig. 5A, B).
Interestingly, CpG complexed with cationic liposomes composed
of Lipofectamine (LTX) and Plus reagent localized in large vesicles
both in wild type and p110c
2/2 cells, and scarcely co-localized
with DNA-PKcs (Fig. 5C). Since wortmannin did not affect CpG
uptake or localization of CpG or DNA-PKcs (data not shown), the
PI3K inhibitor exclusively inhibits the kinase activity of DNA-
PKcs.
Manipulation of CpG localization with cationic liposomes
abolished the effect of p110c deficiency on cytokine
production
It seemed interesting to determine IL-10 production by CpG
complexed with the lipofection reagent, which hardly co-localizes
with DNA-PKcs. When cells were stimulated with this CpG/
lipofection reagent, IL-10 production was decreased both in wild-
type and p110c
2/2 cells (Fig. 6). In addition, the augmentation of
IL-10 production seen in p110c
2/2 cells was completely abolished
using this delivery system (Fig. 6).
Figure 5. Increased co-localization of CpG and DNA-PKcs in p110c
2/2 cells. Macrophages from wild type or p110c
2/2 mice were incubated
with 0.5 mM rhodamine-CpG (A) or rhodamine-CpG/lipofectamine LTX/Plus (C) for 60 min. The cells were washed, fixed, permeabilized, and stained
with anti-DNA-PKcs antibody and Alexa 488-labeled secondary antibody. (B) The imaging data in (A) were quantified and shown as means 6 SD.
doi:10.1371/journal.pone.0026836.g005
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wild type cells, and in lysosomes in p110c
2/2 cells
We next tested the cellular delivery of CpG using an
early endosome marker, EEA1, an endosome marker, dextran,
and an acidic lysosome marker, LysoTracker. Quantitative
analysis of microscopic images showed that more CpG merged
with EEA1 and dextran in wild type cells than in p110c
2/2
cells (Fig. 7A, B, D, E). By contrast, CpG preferentially merged
with LysoTracker in p110c
2/2 cells more than in wild-type
cells (Fig. 7C, F). To further investigate the role of p110c in
CpG localization, Cos7 cells were transfected with p110c
and its mutant forms (unlike macrophages, Cos7 cells do
not express p110c). As shown in Fig. 8, most of the CpG
was co-localized with LysoTracker in Cos7 cells transfected
with vehicle alone, while scarcely co-localized with LysoTracker
in the cells transfected with wild type p110c. Interestingly,
overexpression of a kinase-dead mutant of p110c also inhibited
the acidification of CpG-containing endosome. By contrast,
the Ras-binding domain mutant form showed no effect on
the CpG localization. These results suggest that PI3K p110c
play a role in endosomal acidification independent of its
kinase activity. Since endosomal acidification is known to precede
the endosomal leakage, acidification of CpG containing endosome
may accelerate CpG translocation to the cytosol and the resultant
association with DNA-PKcs to increase IL-10 production in
macrophages.
CpG-induced but not LPS-induced IL-10 production was
suppressed by inhibitors of endosomal acidification
Effect of chemical inhibitors of endosomal acidification [20] on
CpG-induced IL-10 production was next examined. Both NH4Cl
and chloroquine strongly inhibited CpG-induced IL-10 produc-
tion without affecting LPS-induced one (Fig. 9). The result
supported our hypothesis that endosomal acidification is required
for CpG-induced IL-10 production.
Discussion
In this study, we have identified a novel function of PI3K p110c
in the regulation of CpG localization. We have demonstrated this
function using p110c
2/2 macrophages and Cos7 cells transfected
with p110c. In macrophages, more CpG merged with the
endosome markers, EEA1 and dextran, in wild type cells than in
p110c
2/2 cells, whereas preferentially merged with the acidic
lysosome marker, LysoTracker, in p110c
2/2 cells to a greater
extent than in wild-type cells. In Cos7 cells, which do not express
p110c, most of the CpG was co-localized with LysoTracker, and
scarcely co-localized with the dye in the cells transfected with
p110c. Another novel finding reported in this paper is that IL-10
production was increased specifically in p110c
2/2 cells following
CpG-stimulation. In p110c
2/2 cells, the increased acidification of
CpG containing endosomes and the resultant leakage of CpG to
the cytosol, where DNA-PKcs resides, appears to be responsible
for the modulation of cytokine production. For this reason, CpG-
induced, but not LPS-induced, IL-10 production was almost
completely abolished in SCID mice having mutations in DNA-
PKcs. Furthermore, wortmannin, an inhibitor of DNA-PKcs,
inhibited completely CpG-induced IL-10 production both in wild-
type and in p110c
2/2 cells. In addition to these, manipulation of
the delivery system with cationic liposomes, which severely
blocked the cytosolic delivery of CpG both in p110c
2/2 and wild
type cells, resulted in decreased IL-10 production. Finally, an
intriguing point in this study is that the actions of p110c on both
the CpG delivery system and cytokine production were indepen-
dent of its kinase activity.
Several kinase-independent functions of p110c have been
reported previously. Protein complexes containing p110c are
known to activate phosphodiesterase (PDE3B) in cardiomyocytes
to degrade cAMP in a manner independent of its kinase activity
[21,22]. Since increases in the cAMP level results in augmentation
of TLR-mediated IL-12 production, with a decrease in IL-10
production [23], we had hypothesized that the increased IL-10
production in the absence of p110c might be the result of elevated
cAMP levels. To answer this question we tested some reagents
known to increase cAMP, such as forskolin, prostaglandin E2,3 -
isobutyl-1-methylxanthin or dibutyryl cAMP in IL-10 production.
Although these reagents more or less enhanced IL-10 production,
the effect was not specific to CpG stimulation, but rather, was
commonly observed in TLR-stimulation (data not shown). The
other kinase-independent functions of p110c are reported in
vascular repair and platelet aggregation [22]. In addition, wild-
type or the kinase-dead mutant of p110c can block the growth of
human colon cancer cells [24]. Although the mechanism of these
kinase-independent actions of p110c remains to be clarified, a
scaffolding role for p110c has been suggested [22].
p110c
2/2 mice show severe defects in immune responses, and
are protected completely against systemic anaphylaxis [25–28].
Additionally, in models of rheumatoid arthritis, systemic lupus
erythematosus, and atherosclerosis, loss of p110c activity results in
protection against disease progression [29–31]. Since IL-10 is an
anti-inflammatory cytokine, the increased IL-10 production in
Figure 6. The effect of lipofection reagent on CpG-induced
cytokine production. Macrophages from wild type (open bar) or
p110c
2/2 mice (solid bar) were incubated in 24-well plates with
200 ng/mL CpG or CpG/lipofectamine LTX/Plus reagent complex for
18 h. The amount of IL-10 (A) and IL-12 (B) in the medium was
determined by ELISA. The values are the means 6 SD of duplicate
cultures from three independent experiments.
doi:10.1371/journal.pone.0026836.g006
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protection against excessive inflammation. It is also likely that
the increased IL-10 and decreased IL-12 production in p110c
2/2
macrophage might explain partly the development of colorectal
carcinomas in p110c
2/2 mice [24], because the IL-12-mediated
Th1 response favors effective anti-tumor immune responses [32].
Although further studies are needed to confirm the in vivo effect of
p110c on the translocation of CpG, our findings suggest that when
p110c is considered as a drug target for immune diseases
[15,33,34], not only its lipid kinase function, but also its kinase-
independent function should be considered.
Materials and Methods
Reagents
LPS (E. coli serotype 0111: B4), FITC-Dextran (average MW
40 kD) and C5a were from Sigma-Aldrich. Wortmannin was from
Kyowa Medex (Tokyo, Japan). 59-rhodamine-labeled, 59-FITC-
labeled and unlabeled CpG DNA (HPLC-purified phosphorothio-
ate with the sequence of TCC ATG ACG TTC CTG ATG CT)
were synthesized by Hokkaido System Science (Sapporo, Japan).
LysoTracker Red was obtained from Lonza. Lipofectamine LTX
Reagent, Plus Reagent and RPMI 1640 medium were from
Invitrogen. The Protein Assay Kit was purchased from Bio-Rad.
AS-252424 was from Cayman. Anti-pAkt (Ser473) antibody was
from Cell Signalling, anti-Akt1/2 and anti-DNA-PKcs antibodies
were from Santa Cruz, and anti-EEA1 was from GenScript. The
IL-10 ELISA assay kit was from Biolegend.
Animals and cell isolation
All animal experiments were carried out in accordance with the
NIH Guide for Care and Use of Laboratory Animals and
approved by the animal care and use committee at Hiroshima
University (Permit number: A08-23 and A08-46).
Female C57BL/6 mice, 8–12 weeks old, were purchased from
Japan SLC, Inc. SCID, C.B-17/lcr
+/+, C.B-17/lcr-SCID/SCID
mice were purchased from CLEA Japan. p110c
2/2 mice on the
C57BL/6 background were bred and maintained at Akita
University (Akita, Japan). Thioglycollate-elicited macrophages
were harvested from these mice. Briefly, mice were injected
intra-peritoneally with 2 mL 3% thioglycollate broth. After 3 days,
the peritoneal exudate cells were collected by washing the
peritoneal cavity with ice-cold phosphate-buffered saline (PBS).
The cells were seeded at about 5–10610
5 cells/well in 24-well
Figure 7. CpG localization in macrophages from wild type and p110c
2/2 mice. Macrophages from wild type or p110c
2/2 mice were
incubated with 0.5 mM rhodamine-CpG (A, B) or FITC-CpG (C) for 30 min. FITC-dextran (1 mg/ml) (B) or LysoTracker red (50 nM) (C) was added
simultaneously with CpG. The cells were washed and observed as live cells (B and C). In (A), the cells were fixed, permeabilized and stained with anti-
EEA1 antibody and Alexa 488-labeled secondary antibody. The imaging data in (A, B, C) were quantified and shown as means 6 SD in (D, E, F). *;
p,0.05, **; p,0.01.
doi:10.1371/journal.pone.0026836.g007
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RPMI 1640 medium supplemented with 10% fetal bovine serum
(FBS) (MBL, Nagoya, Japan), to allow the cells to adhere to the
wells. Non-adherent cells were removed by washing with PBS and
the attached cells were used for experiments. Cos7 cells [35] were
cultured in DMEM medium supplemented with 10% FBS.
Plasmids and transfection
Mammalian expression plasmids, pcDNA3 (Invitrogen),
pcDNA3 containing wild-type p110c, pcDNA3 containing a
kinase-dead (R947P) mutant, or encoding a Ras binding site
mutant (DASAA; T232D, K251A, K254S, K255A and K256A)
[36] are transfected in to Cos7 cells using the Lipofectamine 2000
Reagent for 24 h.
Western blot
Cells were washed with PBS and lysed in 50 mL lysis buffer
containing 25 mM Tris-HCl (pH 7.4), 0.5% Nonidet P-40,
150 mM NaCl, 1 mM sodium orthovanadate (Na3VO4), 1 mM
EDTA, 0.1% BSA, 20 mM sodium fluoride, 1 mM phenylmethyl-
sulfonyl fluoride, 2 mM leupeptin, 20 mM p-amidinophenylmethyl-
sulfonyl fluoride, and 1 mM dithiothreitol. The cell lysates were
centrifuged at 15,000 rpm for 10 min. Supernatants were
collected and the protein concentration was determined using
the Bio-Rad assay kit. Total cell lysates (100 mg protein) were
mixed with 10 mL5 6sample buffer (62.5 mM Tris, pH 6.8, 1%
SDS, 10% glycerol, 5% 2-mercaptoethanol, and 0.02% bromo-
Figure 8. Effect of overexpression of p110c on CpG localization in Cos7 cells. Cos7 cells were transfected with PI3K p110cor its mutant
forms as described under materials and methods. Cells prepared in this manner were incubated with 50 nM LysoTracker red and 0.5 mM FITC-CpG for
30 min. The cells were washed and observed as live cells.
doi:10.1371/journal.pone.0026836.g008
Figure 9. Effect of inhibitors of lysosomal acidification on IL-10
production. Macrophages from wild type mice were preincubated
with 20 mM NH4Cl, 50 mM Chloroquine or vehicle for 15 min, followed
by the addition of 10 ng/mL LPS or 200 ng/mL CpG, for 18 h. The
amount of IL-10 in the medium was determined by ELISA. The values
are the means 6 SD of duplicate cultures from three independent
experiments. **; p,0.01.
doi:10.1371/journal.pone.0026836.g009
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separated by SDS-PAGE and transferred electrophoretically onto
a polyvinylidene difluoride (PVDF) membrane (Millipore). The
membrane was blocked with 5% skim milk and incubated with the
appropriate antibodies. Antibody binding was detected using a
chemiluminescent substrate (Perkin-Elmer).
ELISA
Macrophage culture supernatants were used for the quantifica-
tion of p40 and IL-10 using a commercially available ELISA kit.
Microscopy
Macrophages in multi-well, glass-bottom dishes (Greiner bio-
one) were allowed to adhere for 60 min before the addition of
rhodamine- or FITC-CpG. Where indicated, FITC-dextran or
LysoTracker Red was added with CpG. The cells were washed
four times to remove excess CpG before live cell imaging.
Alternatively, the cells were fixed with 4% formaldehyde in PBS
for 15 min, permeabilized with PBS containing 0.3% Triton X-
100 and 0.5% BSA for 60 min, and incubated with anti-DNA-
PKcs or anti-EEA1 at 4uC overnight. They were then incubated
with Alexa 488-labeled goat anti-mouse IgG antibody (Fab’)2 for
2 h at room temperature. Cos7 cells were seeded into the culture
wells a day before the transfection. The cells were incubated with
LysoTracker red and FITC-CpG for 15 min as indicated. The
cells were washed four times with PBS before imaging.
Microscopic studies were performed using the Keyence BZ-9000
(Keyence, Osaka, Japan). The imaging data were analyzed by the
BZ-H2A application. Values of (merged area)/(CpG area)6100
were determined from at least 5 imaging data, and the data are
shown as the means 6 SD. Statistical differences were determined
at the level of p,0.05 or 0.01 with Student’s t test.
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